Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Customer B | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage			13.00%
Customer B | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			22.50%		11.30%
Customer D | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			11.90%
Genentech, Inc. and Roche Group | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	45.10%	39.80%	38.20%	42.60%